Licence Variation: Spironolactone For Acne In Women Market Engagement

  Address - United Kingdom

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 104077818

  Document Type - Tender Notices

Description - Description: NHS England has published this Preliminary Market Engagement Notice. It is anticipated that there will be two separate contracts to deliver this, as outlined below.• Contract A: Prepare an application for a major (type II) MHRA Marketi ng Authorisation variation for spironolactone.• Contract B: Submit the pre-prepared application to the MHRA. Only current Marketing Authorisation Holders of spironolactone are eligible to bid for contract B.The licence variation is to add a new indication to the current licence (marketing authorisation) for spironolactone, for treating acne in women.For contract A, the Successful Supplier would need to prepare a dossier for the MHRA including:â

Gt Ref Id - 104077818

Deadline - Mar 14, 2025